Department of Radiation Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
Pediatr Blood Cancer. 2011 Jan;56(1):16-23. doi: 10.1002/pbc.22649. Epub 2010 Oct 14.
This planning study compared RapidArc, fixed-field IMRT (cIMRT), 3D conformal radiotherapy (3D-CRT), and a parallel-opposed pair (POP) for children with retroperitoneal tumors.
Plans were generated in eight patients to treat the PTV (dose range 19.8-45 Gy) while limiting kidney and liver doses. In selected patients, vertebral body (VB) dose heterogeneity was minimized. Cumulative DVH parameters, monitor units (MU), and treatment times were compared for the four techniques using the Wilcoxon matched pairs test.
RapidArc and cIMRT covered target volumes more conformally than 3D-CRT and POP (P = 0.012). There was no difference in the ability to meet kidney dose constraints. A significantly lower volume of the liver received 12 Gy with cIMRT or RapidArc compared with 3D-CRT (P = 0.028). Where VB was included in PTV, VB dose homogeneity was generally within 94-104% of the prescription dose. Time to deliver a single fraction with RapidArc, POP, 3D-CRT, and cIMRT was 1.25 ± 0.01, 1.38 ± 0.10, 2.6 ± 0.45, and 4.02 ± 1.12 min, respectively (P = 0.012). Monitor units for a single fraction with POP, 3D-CRT, RapidArc, and cIMRT were 203 ± 26, 235 ± 32, 325 ± 71, and 665 ± 215, respectively (P < 0.05).
POP resulted in favorable MU, treatment time and dosimetry but had poor conformality. 3D-CRT was more conformal but had higher MU and treatment time. RapidArc and cIMRT were generally no better dosimetrically than conformal techniques. RapidArc was dosimetrically very similar to cIMRT, but resulted in a major reduction in time and MU used to deliver the radiation.
本研究计划比较了 RapidArc、固定野调强放疗(cIMRT)、三维适形放疗(3D-CRT)和对置野放疗(POP)在儿童腹膜后肿瘤治疗中的应用。
为 8 例患者制定治疗计划,靶区剂量范围为 19.8-45Gy,同时限制肾脏和肝脏剂量。在部分患者中,尽量减少椎体(VB)剂量的不均匀性。采用 Wilcoxon 配对检验比较 4 种技术的累积剂量-体积直方图(DVH)参数、机器跳数(MU)和治疗时间。
RapidArc 和 cIMRT 比 3D-CRT 和 POP 更好地覆盖靶区(P = 0.012)。两种调强技术在满足肾脏剂量限制方面无差异。与 3D-CRT 相比,cIMRT 或 RapidArc 可使肝脏接受 12Gy 剂量的体积明显减少(P = 0.028)。当 VB 包括在 PTV 中时,VB 剂量均匀性通常在处方剂量的 94%-104%范围内。RapidArc、POP、3D-CRT 和 cIMRT 单次分割的治疗时间分别为 1.25 ± 0.01、1.38 ± 0.10、2.6 ± 0.45 和 4.02 ± 1.12min(P = 0.012)。POP、3D-CRT、RapidArc 和 cIMRT 单次分割的 MU 分别为 203 ± 26、235 ± 32、325 ± 71 和 665 ± 215(P < 0.05)。
POP 的 MU、治疗时间和剂量学参数具有优势,但适形性较差。3D-CRT 的适形性更好,但 MU 和治疗时间更高。RapidArc 和 cIMRT 的剂量学通常并不优于适形技术。RapidArc 在剂量学上与 cIMRT 非常相似,但可显著减少治疗时间和 MU。